ZA981354B - Aqueous pharmaceutical composition comprising an active ingredient which is highly insoluble in water - Google Patents

Aqueous pharmaceutical composition comprising an active ingredient which is highly insoluble in water

Info

Publication number
ZA981354B
ZA981354B ZA981354A ZA981354A ZA981354B ZA 981354 B ZA981354 B ZA 981354B ZA 981354 A ZA981354 A ZA 981354A ZA 981354 A ZA981354 A ZA 981354A ZA 981354 B ZA981354 B ZA 981354B
Authority
ZA
South Africa
Prior art keywords
water
pharmaceutical composition
active ingredient
aqueous pharmaceutical
highly insoluble
Prior art date
Application number
ZA981354A
Other languages
English (en)
Inventor
Giovanni Cavallo
Leonardo Marchitto
Original Assignee
Angelini Recerche S P A Societ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Angelini Recerche S P A Societ filed Critical Angelini Recerche S P A Societ
Publication of ZA981354B publication Critical patent/ZA981354B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/906—Drug delivery
    • Y10S977/907—Liposome

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA981354A 1997-02-20 1998-02-18 Aqueous pharmaceutical composition comprising an active ingredient which is highly insoluble in water ZA981354B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT97MI000363A IT1289939B1 (it) 1997-02-20 1997-02-20 Composizione farmaceutica acquosa comprendente un principio attivo altamente insolubile in acqua

Publications (1)

Publication Number Publication Date
ZA981354B true ZA981354B (en) 1998-08-17

Family

ID=11376099

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA981354A ZA981354B (en) 1997-02-20 1998-02-18 Aqueous pharmaceutical composition comprising an active ingredient which is highly insoluble in water

Country Status (26)

Country Link
US (1) US6337087B1 (bg)
EP (1) EP0973505B1 (bg)
JP (1) JP4299369B2 (bg)
KR (1) KR100515249B1 (bg)
CN (1) CN1135969C (bg)
AR (1) AR011682A1 (bg)
AT (1) ATE257374T1 (bg)
AU (1) AU740619B2 (bg)
BG (1) BG64367B1 (bg)
CA (1) CA2285985C (bg)
CZ (1) CZ296700B6 (bg)
DE (1) DE69821001T2 (bg)
DK (1) DK0973505T3 (bg)
EA (1) EA002281B1 (bg)
ES (1) ES2213894T3 (bg)
GE (1) GEP20022751B (bg)
HU (1) HU225594B1 (bg)
IL (2) IL131354A0 (bg)
IT (1) IT1289939B1 (bg)
PL (1) PL190987B1 (bg)
PT (1) PT973505E (bg)
SK (1) SK282905B6 (bg)
TR (1) TR199901987T2 (bg)
UA (1) UA63939C2 (bg)
WO (1) WO1998036735A1 (bg)
ZA (1) ZA981354B (bg)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9804192D0 (sv) * 1998-12-03 1998-12-03 Scotia Lipidteknik Ab New formulation
US6075045A (en) * 1999-04-28 2000-06-13 Ajinomoto Co., Inc. Method of treating paralysis of the extremities caused by cerebral infarction
JP4894119B2 (ja) * 2001-09-26 2012-03-14 日油株式会社 脂肪酸含有リポソーム分散液
US20040115226A1 (en) * 2002-12-12 2004-06-17 Wenji Li Free-flowing solid formulations with improved bio-availability of poorly water soluble drugs and process for making the same
WO2004064736A2 (en) * 2003-01-17 2004-08-05 Threshold Pharmaceuticals, Inc. Treatment of benign prostatic hyperplasia using energolytic agents
WO2005105040A2 (en) * 2004-04-26 2005-11-10 Micelle Products, Inc. Water-soluble formulations of fat soluble vitamins and pharmaceutical agents and their applications
US8999292B2 (en) 2012-05-01 2015-04-07 Translatum Medicus Inc. Methods for treating and diagnosing blinding eye diseases
AU2019398117B2 (en) * 2018-12-11 2021-04-15 Disruption Labs Inc. Compositions for the delivery of therapeutic agents and methods of use and making thereof
CN111759807B (zh) * 2019-04-01 2021-06-01 上海谷森医药有限公司 一种环孢素脂质体及其制备方法
CA3144861A1 (en) 2019-06-25 2020-12-30 Translatum Medicus, Inc. Processes of making 2-((1-benzyl-1h-indazol-3-yl)methoxy)-2-methylpropanoic acid and its derivatives

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1264668C (en) * 1984-06-20 1990-01-23 EXTRUSION TECHNIQUES FOR THE PRODUCTION OF LIPOSOMES
DE4038075C1 (en) * 1990-11-29 1992-03-19 B. Braun Melsungen Ag, 3508 Melsungen, De Encapsulating solid or liq. lipophilic agents - comprises mixing hydration medium with phospholipid increasing temp. to above soln. phase change temp. and adding remaining medium
IT1254995B (it) * 1992-06-24 1995-10-11 Farmaco contenente melatonina e/o agonisti, con somministrazione particolarmente efficace nelle patologie che interferiscono con i ritmi circandiani
AT396755B (de) * 1992-07-09 1993-11-25 Oesko Gmbh Verfahren zum reinigen eines rauchgasstromes mit hilfe einer waschflüssigkeit
FR2716110B1 (fr) * 1994-02-16 1996-04-05 Roussel Uclaf Compositions cosmétiques ou pharmaceutiques comprenant des liposomes.
DE4447770C2 (de) * 1994-08-20 2002-12-19 Max Delbrueck Centrum Verfahren zur Herstellung von liposomal verkapseltem Taxol
WO1996040064A1 (en) * 1995-06-07 1996-12-19 Nexstar Pharmaceuticals, Inc. Liposomal cyclosporin formulations as agents for immunosuppression and multiple drug resistant indications

Also Published As

Publication number Publication date
KR20000075480A (ko) 2000-12-15
UA63939C2 (uk) 2004-02-16
CZ296700B6 (cs) 2006-05-17
CN1255057A (zh) 2000-05-31
DK0973505T3 (da) 2004-05-03
CN1135969C (zh) 2004-01-28
HUP0000910A2 (hu) 2000-10-28
HUP0000910A3 (en) 2000-11-28
EP0973505A1 (en) 2000-01-26
DE69821001T2 (de) 2004-11-11
DE69821001D1 (de) 2004-02-12
AR011682A1 (es) 2000-08-30
TR199901987T2 (xx) 1999-11-22
JP2001519775A (ja) 2001-10-23
HU225594B1 (en) 2007-05-02
EA002281B1 (ru) 2002-02-28
SK111199A3 (en) 2000-06-12
ATE257374T1 (de) 2004-01-15
ITMI970363A1 (it) 1998-08-20
SK282905B6 (sk) 2003-01-09
WO1998036735A1 (en) 1998-08-27
AU6398798A (en) 1998-09-09
US6337087B1 (en) 2002-01-08
BG103739A (bg) 2000-06-30
AU740619B2 (en) 2001-11-08
CA2285985A1 (en) 1998-08-27
JP4299369B2 (ja) 2009-07-22
EP0973505B1 (en) 2004-01-07
CZ292699A3 (cs) 2000-01-12
IL131354A (en) 2010-06-30
PL190987B1 (pl) 2006-02-28
PT973505E (pt) 2004-05-31
GEP20022751B (en) 2002-08-26
IL131354A0 (en) 2001-01-28
KR100515249B1 (ko) 2005-09-16
IT1289939B1 (it) 1998-10-19
EA199900750A1 (ru) 2000-04-24
BG64367B1 (bg) 2004-12-30
CA2285985C (en) 2008-01-29
ES2213894T3 (es) 2004-09-01
PL335208A1 (en) 2000-04-10

Similar Documents

Publication Publication Date Title
HUP0100178A3 (en) Tetrahydro-naphtiridinyl-imidazolydinyl-carboxylic acid derivatives and pharmaceutical compositions thereof
HUP0004310A3 (en) Cyclic amino acids, and derivatives thereof and pharmaceutical compositions comprising the said compounds as active agents
ZA965866B (en) 6-Dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients
ZA9610650B (en) 1-Phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients
HRP950397B1 (en) Aqueous risperidone formulations
ZA982872B (en) Pharmaceutical formulation
HUP0001269A3 (en) 2-oxo-1-azetidine sulfonic acid derivatives and combined pharmaceutical compositions thereof
HUP0102369A3 (en) Amino acid derivatives and drugs containing the same as the active ingredient
ZA981354B (en) Aqueous pharmaceutical composition comprising an active ingredient which is highly insoluble in water
IL136682A0 (en) Aqueous insecticidal pour-on formulation
ZA9811655B (en) Phenylaminoalkylcarboxylic acid derivatives and pharmaceutical compositions comprising the same
IL126892A0 (en) Pharmaceutical compositions for the sustained release of insoluble active principles
PL349393A1 (en) Sulphonyloxazolamines as therapeutic active ingredients
EP1047435A4 (en) USE OF AN AQUEOUS SOLUTION IN THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF LIVE ANIMALS
HUP0203756A3 (en) Ciclesonide-containing aqueous pharmaceutical composition
GB9709739D0 (en) Pharmaceutical formulation
PL337807A1 (en) Sertralin dosage formulation in the form of a gelatine-encapsulated solution
GB9818927D0 (en) Pharmaceutical formulation
EP1142565A4 (en) AQUEOUS THERAPEUTIC COMPOSITIONS
SI0973505T1 (en) Aqueous pharmaceutical composition comprising an active ingredient which is highly insoluble in water
GB9822333D0 (en) Pharmaceutical formulation
GB9817470D0 (en) Pharmaceutical formulation
GB9802617D0 (en) Pharmaceutical formulation
HU9702369D0 (en) Pharmaceutical composition of natural active components
GB9817217D0 (en) Pharmaceutical formulation